NCT00270049 2011-05-18Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic LeukemiaJohnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 2 Completed195 enrolled